The United States In Vitro Diagnostics (IVD) Market is Forecast to Reach nearly US$ 37 Billion by 2026.
The United States In Vitro Diagnostics (IVD) market is predicted to reach nearly US$ 37 Billion by 2026. In-vitro Diagnostics (IVD) serves a key role in the healthcare value chain by significantly influencing the quality of health outcomes, patient treatment, care and downstream resource requirements. With an aging population, technological advances and advent of point of care diagnostics, United States IVD market is slated to show substantial growth in the future. The increase in the US in vitro diagnostics market is majorly driven by high prevalence of chronic diseases, such as heart diseases, cancer, asthma, and diabetes. It is estimated that these diseases are responsible for the majority of deaths in the United States, killing more than 1.7 million US citizens annually. All of these conditions can be diagnosed and monitored using IVD products. Thus, IVDs have proved to be beneficial in managing these chronic conditions. However, some of the factors limiting the growth of the market are a lack of proper reimbursement policies and lack of skilled lab technicians.
Impact of COVID-19 on United States In-Vitro Diagnostics Market
The COVID–19 outbreak has become a global stress test. The disease has infected over 110 Million people worldwide. Globally the death toll has reached 2,432,622 according to the latest statistics from the Worldometers (as of February 17, 2021). The number is still growing, and the duration of the pandemic is still difficult to predict. The COVID-19 outbreak has created a sense of urgency and panic among people globally. While people are being advised to stay indoors, healthcare professionals and researchers have registered a state of urgency. In this scenario, the in-vitro diagnostics forms the crux of increased testing. Manufacturers in the in-vitro diagnostic market are focusing on developing novel technologies for maximum testing within a minimum period. The novel coronavirus has accelerated the research and development activities in the in-vitro diagnostics market. Development and production in maximum numbers is the need of the hour. Therefore, quick FDA approvals are proving to be the cherry on the cake for the growth of the in-vitro diagnostic market.
United States In-Vitro Diagnostics Market - Application Segments Analysis
- On segment basis, the POC - Professional segment accounted for highest share of the United States IVD market, followed by the POC - OTC diabetes segment.
- Immunoassays have become one of the primary and indispensable tools in the diagnosis and monitoring of all diseases and medical conditions.
- The non-infectious immunoassays contribute significantly to the United States IVD market.
- It is anticipated that the molecular microbiology segment will account for around 10% share of the United States IVD market by 2026.
- The Clinical chemistry segment contributed over 7% to the United States IVD market in 2020.
- Histology and Hematology segments are competing closely with each other to grab maximum share of the pie.
- Urinalysis captures least share of the United States in vitro diagnostics market.
United States In-Vitro Diagnostics Market - Products Analysis
- Instruments is the leading product segment of the United States In-Vitro Diagnostics (IVD) market, followed by the reagents segment.
- The software segment contributed nearly 15% share to the United States IVD market in 2020, due to growing preference for reliable and efficient diagnostic software.
- Services segment captured least share of the United States in vitro diagnostics market, but it is likely to show impressive growth throughout the forecast period.
United States In-Vitro Diagnostics Market - Regional Analysis
- The largest share of the US in vitro diagnostics market is currently in the South of the country with the West being second.
- Midwest region accounts for over 22% share of the total US IVD market in 2020, as an increasing number of accredited laboratories opening in that area.
- The North East region accounted for least share of the total US IVD market.
United States In-Vitro Diagnostics Market - End Users Analysis
- Hospitals captures highest share of the United States IVD market, owing to the large volume of diagnostic tests carried out in hospitals.
- An increasing number of independent accredited laboratories are opening all over the country, thus driving the market for laboratories segment.
- The other end users (Self Testing, Retail Clinics, Physician Office Labs, Others) segment contributed nearly a quarter to the United States IVD market.
This report provides a comprehensive assessment of the fast-evolving, high-growth United States IVD Market.
This 243 Page report with 73 Figures and 8 Tables has been analyzed from 10 View Points:
1) United States IVD Market and Forecast (2013 - 2026)
2) Impact of COVID-19 on United States IVD Market
3) United States IVD Market Share and Forecast (2013 - 2026)
4) United States IVD Market & Forecast - By Application Segments (2013 - 2026)
5) United States IVD Market & Forecast - By Products (2013 - 2026)
6) United States IVD Market & Forecast - By Region (2013 - 2026)
7) United States IVD Market & Forecast - By End Users (2013 - 2026)
8) United States IVD Market & Forecast - Company Profiles (2013 - 2026)
9) United States IVD Market - Major Deals
10) United States IVD Industry Drivers & Challenges
By Application Segments - United States In-Vitro Diagnostics Market
1. Clinical Chemistry
2. Microbiology -ID/AST
3. Microbiology - Molecular
4. POC - Professional
5. POC - OTC Diabetes
6. POC - Others
7. Immunoassay - Infectious
8. Immunoassay - Others
9. Urinalysis
10. Molecular - Non-Infectious
11. Coagulation
12. Histology
13. Hematology
14. Blood Testing and Typing
15. Flow Cytometry
By Products - United States In-Vitro Diagnostics Market
- Instruments
- Reagents
- Software
- Services
By Region - United States In-Vitro Diagnostics Market
- South
- West
- Midwest
- North East
By End Users - United States In-Vitro Diagnostics Market
- Hospitals
- Laboratories
- Others
United States In-Vitro Diagnostics Market - Company Profiles
1. Roche Diagnostic
2. Abbott Laboratories
3. Siemens Healthineers
4. Danaher Corporation
5. Thermo Fisher Scientific
6. Sysmex Corporation
7. Biomerieux
8. Bio-Rad Laboratories, Inc
9. Becton Dickinson and Company
Table of Contents
1. Executive Summary
2. Impact of COVID-19 on United States In-Vitro Diagnostics Market
3. United States - In-Vitro Diagnostics Market and Forecast (2013 - 2026)
4. United States - In-Vitro Diagnostics Market Share and Forecast (2013 - 2026)
4.1 By Application Segments - United States In-Vitro Diagnostics Market Share and Forecast
4.2 By Products - United States In-Vitro Diagnostics Market Share and Forecast
4.3 By Region - United States In-Vitro Diagnostics Market Share and Forecast
4.4 By End Users - United States In-Vitro Diagnostics Market Share and Forecast
5. By Application Segments - United States In-Vitro Diagnostics Market and Forecast (2013 - 2026)
5.1 United States - Clinical Chemistry Market and Forecast
5.2 United States - Microbiology -ID/AST Market and Forecast
5.3 United States - Microbiology - Molecular Market and Forecast
5.4 United States - POC - Professional Market and Forecast
5.5 United States - POC - OTC Diabetes Market and Forecast
5.6 United States - POC - Others Market and Forecast
5.7 United States - Immunoassay - Infectious Market and Forecast
5.8 United States - Immunoassay - Others Market and Forecast
5.9 United States - Urinalysis Market and Forecast
5.10 United States - Molecular - Non-Infectious Market and Forecast
5.11 United States - Coagulation Market and Forecast
5.12 United States - Histology Market and Forecast
5.13 United States - Hematology Market and Forecast
5.14 United States - Blood Testing and Typing Market and Forecast
5.15 United States - Flow Cytometry Market and Forecast
6. By Products - United States In-Vitro Diagnostics Market and Forecast (2013 - 2026)
6.1 United States - In-Vitro Diagnostics Instruments Market and Forecast
6.2 United States - In-Vitro Diagnostics Reagents Market and Forecast
6.3 United States - In-Vitro Diagnostics Services Market and Forecast
6.4 United States - In-Vitro Diagnostics Software Market and Forecast
7. By Region - United States In-Vitro Diagnostics Market and Forecast (2013 - 2026)
7.1 South - In-Vitro Diagnostics Market and Forecast
7.2 West - In-Vitro Diagnostics Market and Forecast
7.3 Midwest - In-Vitro Diagnostics Market and Forecast
7.4 North East - In-Vitro Diagnostics Market and Forecast
8. By End User - United States In-Vitro Diagnostics Market and Forecast (2013 - 2026)
8.1 United States - Hospital In-Vitro Diagnostics Market and Forecast
8.2 United States - Laboratories In-Vitro Diagnostics Market and Forecast
8.3 United States - Others In-Vitro Diagnostics Market and Forecast
9. United States In-Vitro Diagnostics Market - Company Profiles
9.1 Roche Diagnostics
9.1.1 Company Overview
9.1.2 Recent Developments
9.1.3 Sales and Forecast
9.2 Abbott Diagnostics
9.2.1 Company Overview
9.2.2 Recent Developments
9.2.3 Sales and Forecast
9.3 Siemens Healthineers
9.3.1 Company Overview
9.3.2 Recent Developments
9.3.3 Sales and Forecast
9.4 Danaher Corporation
9.4.1 Company Overview
9.4.2 Recent Developments
9.4.3 Sales and Forecast
9.5 Thermo Fisher Scientific
9.5.1 Company Overview
9.5.2 Recent Developments
9.5.3 Sales and Forecast
9.6 Sysmex Corporation
9.6.1 Company Overview
9.6.2 Recent Developments
9.6.3 Sales and Forecast
9.7 Biomerieux
9.7.1 Company Overview
9.7.2 Recent Developments
9.7.3 Sales and Forecast
9.8 Bio-Rad Laboratories, Inc
9.8.1 Company Overview
9.8.2 Recent Developments
9.8.3 Sales and Forecast
9.9 Becton Dickinson and Company
9.9.1 Company Overview
9.9.2 Recent Developments
9.9.3 Sales and Forecast
10. United States IVD Market - Major Deals
10.1 2021
10.2 2020
10.3 2019
10.4 2018
10.5 2017
10.6 2016
11. United States In-Vitro Diagnostics Market - Growth Drivers
11.1 High Prevalence of Chronic and Infectious Diseases
11.2 Increase in geriatric population
11.3 Technology Advancement Spurring the IVD Market
11.4 Increasing Adoption of Automated Instruments and Automation in Laboratories Drives United States IVD Market
12. United States In-Vitro Diagnostics Market - Challenges
12.1 Cumbersome Reimbursement Procedure
12.2 Shortage of Lab Technicians
List of Figures:
Figure 3-1: United States - In-vitro Diagnostics Market (Million US$), 2013 - 2020
Figure 3-2: United States - Forecast for In-vitro Diagnostics Market (Million US$), 2021 - 2026
Figure 5-1: United States In-vitro Diagnostics - Clinical Chemistry Market (Million US$), 2013 - 2020
Figure 5-2: United States In-vitro Diagnostics - Forecast for Clinical Chemistry Market (Million US$), 2021 - 2026
Figure 5-3: United States In-vitro Diagnostics - Microbiology -ID/AST Market (Million US$), 2013 - 2020
Figure 5-4: United States In-vitro Diagnostics - Forecast for Microbiology -ID/AST Market (Million US$), 2021 - 2026
Figure 5-5: United States In-vitro Diagnostics - Microbiology - Molecular Market (Million US$), 2013 - 2020
Figure 5-6: United States In-vitro Diagnostics - Forecast for Microbiology - Molecular Market (Million US$), 2021 - 2026
Figure 5-7: United States In-vitro Diagnostics - POC - Professional Market (Million US$), 2013 - 2020
Figure 5-8: United States In-vitro Diagnostics - Forecast for POC - Professional Market (Million US$), 2021 - 2026
Figure 5-9: United States In-vitro Diagnostics - POC - OTC Diabetes Market (Million US$), 2013 - 2020
Figure 5-10: United States In-vitro Diagnostics - Forecast for POC - OTC Diabetes Market (Million US$), 2021 - 2026
Figure 5-11: United States In-vitro Diagnostics - POC - Others Market (Million US$), 2013 - 2020
Figure 5-12: United States In-vitro Diagnostics - Forecast for POC - Others Market (Million US$), 2021 - 2026
Figure 5-13: United States In-vitro Diagnostics - Immunoassay - Infectious Market (Million US$), 2013 - 2020
Figure 5-14: United States In-vitro Diagnostics - Forecast for Immunoassay - Infectious Market (Million US$), 2021 - 2026
Figure 5-15: United States In-vitro Diagnostics - Immunoassay - Others Market (Million US$), 2013 - 2020
Figure 5-16: United States In-vitro Diagnostics - Forecast for Immunoassay - Others Market (Million US$), 2021 - 2026
Figure 5-17: United States In-vitro Diagnostics - Urinalysis Market (Million US$), 2013 - 2020
Figure 5-18: United States In-vitro Diagnostics - Forecast for Urinalysis Market (Million US$), 2021 - 2026
Figure 5 19: United States In-vitro Diagnostics - Molecular - Non-Infectious Market (Million US$), 2013 - 2020
Figure 5-20: United States In-vitro Diagnostics - Forecast for Molecular - Non-Infectious Market (Million US$), 2021 - 2026
Figure 5-21: United States In-vitro Diagnostics - Coagulation Market (Million US$), 2013 - 2020
Figure 5-22: United States In-vitro Diagnostics - Forecast for Coagulation Market (Million US$), 2021 - 2026
Figure 5-23: United States In-vitro Diagnostics - Histology Market (Million US$), 2013 - 2020
Figure 5-24: United States In-vitro Diagnostics - Forecast for Histology Market (Million US$), 2021 - 2026
Figure 5-25: United States In-vitro Diagnostics - Hematology Market (Million US$), 2013 - 2020
Figure 5-26: United States In-vitro Diagnostics - Forecast for Hematology Market (Million US$), 2021 - 2026
Figure 5-27: United States In-vitro Diagnostics - Blood Testing and Typing Market (Million US$), 2013 - 2020
Figure 5-28: United States In-vitro Diagnostics - Forecast for Blood Testing and Typing Market (Million US$), 2021 - 2026
Figure 5-29: United States In-vitro Diagnostics - Flow Cytometry Market (Million US$), 2013 - 2020
Figure 5-30: United States In-vitro Diagnostics - Forecast for Flow Cytometry Market (Million US$), 2021 - 2026
Figure 6-1: United States In-vitro Diagnostics - Instruments Market (Million US$), 2013 - 2020
Figure 6-2: United States In-vitro Diagnostics - Forecast for Instruments Market (Million US$), 2021 - 2026
Figure 6-3: United States In-vitro Diagnostics - Reagents Market (Million US$), 2013 - 2020
Figure 6-4: United States In-vitro Diagnostics - Forecast for Reagents Market (Million US$), 2021 - 2026
Figure 6-5: United States In-vitro Diagnostics - Services Market (Million US$), 2013 - 2020
Figure 6-6: United States In-vitro Diagnostics - Forecast for Services Market (Million US$), 2021 - 2026
Figure 6-7: United States In-vitro Diagnostics - Software Market (Million US$), 2013 - 2020
Figure 6-8: United States In-vitro Diagnostics - Forecast for Software Market (Million US$), 2021 - 2026
Figure 7-1: United States In-vitro Diagnostics - South Region Market (Million US$), 2013 - 2020
Figure 7-2: United States In-vitro Diagnostics - Forecast for South Region Market (Million US$), 2021 - 2026
Figure 7-3: United States In-vitro Diagnostics - West Region Market (Million US$), 2013 - 2020
Figure 7-4: United States In-vitro Diagnostics - Forecast for West Region Market (Million US$), 2021 - 2026
Figure 7-5: United States In-vitro Diagnostics - Midwest Region Market (Million US$), 2013 - 2020
Figure 7-6: United States In-vitro Diagnostics - Forecast for Midwest Region Market (Million US$), 2021 - 2026
Figure 7-7: United States In-vitro Diagnostics - North East Region Market (Million US$), 2013 - 2020
Figure 7-8: United States In-vitro Diagnostics - Forecast for North East Region Market (Million US$), 2021 - 2026
Figure 8-1: United States In-vitro Diagnostics - Hospital Market (Million US$), 2013 - 2020
Figure 8-2: United States In-vitro Diagnostics - Forecast for Hospital Market (Million US$), 2021 - 2026
Figure 8-3: United States In-vitro Diagnostics - Laboratories Market (Million US$), 2013 - 2020
Figure 8-4: United States In-vitro Diagnostics - Forecast for Laboratories Market (Million US$), 2021 - 2026
Figure 8-5: United States In-vitro Diagnostics - Others Market (Million US$), 2013 - 2020
Figure 8-6: United States In-vitro Diagnostics - Forecast for Others Market (Million US$), 2021 - 2026
Figure 9-1: Roche Diagnostics - Global Sales (Million US$), 2013 - 2020
Figure 9-2: Roche Diagnostics - Forecast for Global Sales (Million US$), 2021 - 2026
Figure 9-3: Abbott Laboratories - Global Diagnostics Sales (Million US$), 2013 - 2020
Figure 9-4: Abbott Laboratories - Forecast for Global Diagnostics Sales (Million US$), 2021 - 2026
Figure 9-5: Siemens Healthineers - Global Diagnostics Sales (Million US$), 2013 - 2020
Figure 9-6: Siemens Healthineers - Forecast for Global Diagnostics Sales (Million US$), 2021 - 2026
Figure 9-7: Danaher Corporation - Global Diagnostics Sales (Million US$), 2014 - 2020
Figure 9-8: Danaher Corporation - Forecast for Global Diagnostics Sales (Million US$), 2021 - 2026
Figure 9-9: Thermo Fisher Scientific - Global Diagnostics Sales (Million US$), 2013 - 2020
Figure 9-10: Thermo Fisher Scientific - Forecast for Global Diagnostics Sales (Million US$), 2021 - 2026
Figure 9-11: Sysmex Corporation - Global Diagnostics Sales (Million US$), 2014 - 2019
Figure 9-12: Sysmex Corporation - Forecast for Global Diagnostics Sales (Million US$), 2020 - 2026
Figure 9-13: bioMérieux - Global Diagnostics Sales (Million US$), 2015 - 2019
Figure 9-14: bioMérieux - Forecast for Global Diagnostics Sales (Million US$), 2020 - 2026
Figure 9-15: Bio-Rad Laboratories, Inc. - Global Diagnostics Sales (Million US$), 2014 - 2020
Figure 9-16: Bio-Rad Laboratories, Inc. - Forecast for Global Diagnostics Sales (Million US$), 2021 - 2026
Figure 9-17: Becton, Dickinson and Company - Global Diagnostics Sales (Million US$), 2014 - 2020
Figure 9-18: Becton, Dickinson and Company - Forecast for Global Diagnostics Sales (Million US$), 2021 - 2026
Figure 11-1: United States - Geriatric Population and Forecast (Million), 2016, 2018, 2060
List of Tables:
Table 4-1: By Application Segments - United States In-Vitro Diagnostics Market Share (Percent), 2013 - 2020
Table 4-2: By Application Segments - Forecast for United States In-Vitro Diagnostics Market Share (Percent), 2021 - 2026
Table 4-3: By Products - United States In-Vitro Diagnostics Market Share (Percent), 2013 - 2020
Table 4-4: By Products - Forecast for United States In-Vitro Diagnostics Market Share (Percent), 2021 - 2026
Table 4-5: By Region- United States In-Vitro Diagnostics Market Share (Percent), 2013 - 2020
Table 4-6: By Region- Forecast for United States In-Vitro Diagnostics Market Share (Percent), 2021 - 2026
Table 4-7: By End Users - United States In-Vitro Diagnostics Market Share (Percent), 2013 - 2020
Table 4-8: By End Users - Forecast for United States In-Vitro Diagnostics Market Share (Percent), 2021 - 2026
Companies Mentioned
- Roche Diagnostic
- Abbott Laboratories
- Siemens Healthineers
- Danaher Corporation
- Thermo Fisher Scientific
- Sysmex Corporation
- Biomerieux
- Bio-Rad Laboratories, Inc
- Becton Dickinson and Company
